Biodistribution and Metabolism of I-123 Labelled Fatty Acid ( I ) - < I-123 > 15-( p-iodophenyl ) pentadecanoic acid ( IPPA ).
- Author:
Chang Soon KOH
;
Myung Chul LEE
;
June Key CHUNG
;
Dong Soo LEE
;
Jae Min JEONG
;
Young Soo CHANG
;
Yong Sup SUH
- Publication Type:Clinical Trial ; In Vitro ; Original Article
- Keywords:
I-123-IPPA;
Biodistribution;
dynamic SPECT
- MeSH:
Animals;
Dogs;
Fatty Acids;
Humans;
Korea;
Lung;
Metabolism*;
Mice;
Muscles;
Myocardial Infarction;
Myocardium;
Rats;
Tomography, Emission-Computed, Single-Photon
- From:Korean Journal of Nuclear Medicine
1998;32(1):50-60
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
I-123 labelled fatty acids are suitable for investigation of regional myocardial metabolism, so they are on the clinical trial. However, the precise properties of these materials are not characterized yet. We have synthesized phenylpentadecanoic acid and labeled this compound with I-123. The purpose of this study was to examine the stability, biodistribution, metabolism and SPECT imaging of [I-123]15-(p-iodophenyl)pentadecanoic acid(I-123-IPPA) that we made. The stability test of I-123-IPPA in serum of rat, mouse and human showed no free I-123 after 1 hour. In biodistribution study in mice for various time intervals after injection(5, 10, 15, 30, 60 minutes), uptake in myocardium was 14.5%ID/g(5 min), and 1.9%ID/heart(5 min), while uptake in muscles was 2.6%ID/g(5 min). Myocardium to blood ratio and myocardium to lung ratio increased for 5 min after injection and then decreased rapidly. Chromatographic data of rat blood and urine showed that little PPA was found in blood and urine 15-20 min after injection. The myocardial I-123-IPPA SPECT images of a dog with myocardial infarction showed defects similar to those of Tc-99m-MIBI and F-18-FDG. These data suggest that I-123-IPPA is quite stable in vitro and shows favorable biodistribution in mice. SPECT imaging with I-123-IPPA demonstrated infarct zone as photon defect in dog model of myocardial infarction. I-123-IPPA may be used for the evaluation of fatty acid metabolism in clinical trials in Korea.
